Intelliheart tests in Amcal pharmacies
Friday, 13 June, 2008
IM Medical (ASX: IMI) has reached an exclusive agreement with Sigma Pharmaceuticals that will see the Intelliheart cardiac risk assessment tests sold through Sigma's Amcal network.
The Amcal network includes over 700 Amcal, Amcal Max and Guardian pharmacies throughout the country.
The product will initially be rolled out to over 200 pharmacies throughout Victoria in July. Stores in other states will begin stocking the product in the next few months.
Under the agreement Sigma has the right to produce and market other products using the Intelliheart brand name.
Intelliheart is the only widely available diagnostic which tests for both heart rate variability and arterial stiffness.
Liquid fat treatment provides hope for rare childhood disease
A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in...
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
